Clinical Trials Browser

Phase 2 × Advanced Solid Tumors × PM 01183 × Clear all

NCT02454972 2023-03-02

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

Phase 2 Completed

345 enrolled 34 charts 2 FDA

Other solid neoplasm

Advanced Solid Tumors